The Recall Desk
Agency classClass IIOur severity:HighFDA (Drugs)·D-0722-2017·Announced 2017-05-24

Key Pharmacy Recalls Hydroxo-B12 Injections Due to Sterility Concerns

Key Pharmacy and Compounding Center is recalling specific lots of Hydroxo-B12 injections because the firm cannot assure the sterility of the products.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II and involves a risk-of-harm product (sterility failure) where no specific injuries or illnesses have been reported in the source text.

Plain-English summary

Key Pharmacy and Compounding Center is recalling 50 vials of Hydroxo-B12 injections, including 1 mL and 2 mL single-dose vials. The recall involves three specific lots with expiration dates in April 2017. The products were distributed nationwide in the U.S.A., as well as in Australia and Canada.

The recall was initiated due to a lack of assurance of sterility. The firm is recalling these sterile compounded drugs while they are still within their expiration dates to address this quality concern.

Consumers and healthcare providers should stop using the affected vials and contact their pharmacist or the recalling firm for further instructions on disposal or replacement.

The recalled product

Product
HYDROXO-B12 1ML SDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, 1 mL glass/ Single Dose vial, Prepared by Key Compounding Pharmacy HYDROXO-B12 2ML SDV 10MG/ML INJ, Injection, 10mg/mL, RX only, 2 mL glass/ Single Dose vial.
Manufacturer
Key Pharmacy and Compounding Center
Category
Drug — Compounded Injectable
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (6)

  • Lot # t01-17-2017@103
  • Exp 4/18/2017
  • t01-23-2017@80
  • Exp 4/24/2017
  • t02-10-2017@120
  • Exp 4/30/2017.

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 79 recalled by Key Pharmacy and Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 79 products in this recall →

Related recalls

Same manufacturer · Key Pharmacy and Compounding Center

See all →

Same hazard · sterility failure

See all →

Similar recalls